Filter
356
Filtered Results: 356
Text search:
Sauli,
E.
et
al.
Featured
Recommendations
37
New Publications
68
Language
Document type
No document type
149
Studies & Reports
111
Guidelines
46
Manuals
20
Strategic & Response Plan
10
Fact sheets
9
Training Material
8
Situation Updates
2
Infographics
1
Countries / Regions
Global
33
Middle East and North Africa
12
Syria
10
Venezuela
7
Russia
7
Yemen
7
Africa
6
Latin America and the Carribbean
6
Colombia
5
Mozambique
5
Saudi Arabia
5
Sudan
5
Nigeria
4
Burkina Faso
4
Cambodia
4
Jordan
4
Germany
4
Western and Central Europe
4
Lebanon
4
South Africa
4
Brazil
4
Iraq
4
Pakistan
4
Mexico
3
Afghanistan
3
Peru
3
Philippines
3
Asia
3
Tanzania
3
Eastern Europe
3
Palestine
3
Libya
3
South Sudan
3
Somalia
3
Nepal
2
Kenya
2
China
2
Iran
2
Senegal
2
Malawi
2
Morocco
2
Qatar
2
Congo, Democratic Republic of
2
Paraguay
2
Tunisia
2
Portugal
2
Uganda
2
Egypt
2
Ethiopia
2
Mali
2
Angola
2
Indonesia
2
India
2
Thailand
1
Lesotho
1
Turkey
1
Ghana
1
Benin
1
Sierra Leone
1
Rwanda
1
Albania
1
Canada
1
Laos
1
Niger
1
Mauritania
1
Armenia
1
Haiti
1
Guinea-Bissau
1
West and Central Africa
1
Spain
1
Israel
1
East and Southern Africa
1
Argentina
1
Bangladesh
1
Vietnam
1
Papua New Guinea
1
Djibouti
1
Romania
1
Greece
1
Georgia
1
Central African Republic
1
Chad
1
Botswana
1
Liberia
1
Ecuador
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
90
Clinical Guidelines
43
Public Health
28
Women & Child Health
21
Key Resources
16
Capacity Building
6
Pharmacy & Technologies
4
Toolboxes
COVID-19
52
Mental Health
39
NTDs
22
Planetary Health
19
AMR
16
TB
15
Rapid Response
14
Disability
13
Health Financing Toolbox
13
HIV
11
Refugee
10
NCDs
10
Conflict
9
Global Health Education
6
Caregiver
5
Pharmacy
5
Natural Hazards
3
Cholera
3
Ebola & Marburg
3
Social Ethics
3
Specific Hazards
2
Polio
2
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...
Abschlussbericht. Repräsentative Untersuchung von geflüchteten Fraün in unterschiedlichen Bundesländern in Deutschland
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
This is a case-ascertained prospective investigation of all identified health care contacts working in a health care facility in which a laboratory confirmed 2019-nCoV infected patient (see 2.2 Study population) receives care. Note that this study can be done in health care facilities at all 3 level...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
DHS Further Analysis Reports No 102
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
Climate change, increasing population densities, and intensified globalisation in trade, travel and migration are among the most important factors shaping the 21st century. Each impacts upon population health and the risk of infectious disease, particularly those originating at the human-animal-envi...
To realize Agenda 2030, aid agencies, private philanthropies, and their partners in the Global South need better data to monitor how official development finance (ODF) dollars advance the Sustainable Development Goals (SDGs) and avoid missing the mark. In this report, we summarize the results of a n...
The equation is simple: we cannot effectively respond to a global pandemic when millions of people are still caught in warzones. We cannot treat sick people when hospitals are being bombed, or prevent the spread of coronavirus when tens of millions are forced to flee from violence. We must have a gl...
TNew data from the World Health Organization reveal that the COVID-19 pandemic has disrupted malaria services, leading to a marked increase in cases and deaths.
According to WHO’s latest World malaria report, there were an estimated 241 million malaria cases and 627 000 malaria deaths worldwide i...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
This report is a comprehensive statistical overview of female genital mutilation/cutting (FGM/C) in the 29 countries where the practice is concentrated. Analysis of the data reflects current perspectives on FGM/C, informed by the latest policy, programmatic and theoretical evidence.
This is the 19th annual Landmine Monitor report. It is the sister publication to the Cluster Munition Monitor report, first published in November 2010.
Landmine Monitor 2016 provides a global overview of the landmine situation. Chapters on developments in specific countries and other areas are ava...
The aim of the meeting was to broaden the network’s initiatives. Preliminary work involved integrating laboratory testing for skin NTDs other than Buruli ulcer, such as cutaneous leishmaniasis, mycetoma, leprosy and yaws, while extending the network’s reach to encompass additional laboratories.
